Moneycontrol

Budget 2023Budget 2023
Live: LIVE: Bajar Gupshup

Dr Reddy’s reports 77% growth in Q3 consolidated profit

Dr Reddy's Q3 result: The drugmaker reported a 27% YoY increase in consolidated revenues at Rs 6,770 crore for the reported quarter.

January 25, 2023 / 05:45 PM IST
The Hyderabad-based drugmaker also reported a 27 percent increase in consolidated revenue at Rs 6,770 crore as against Rs 5,320 crore in the year-ago period

The Hyderabad-based drugmaker also reported a 27 percent increase in consolidated revenue at Rs 6,770 crore as against Rs 5,320 crore in the year-ago period

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Pharma major Dr Reddy's Laboratories on January 25 reported a 77 percent growth in consolidated net profit at Rs 1,247 crore for the quarter ended December 31, 2022 as against Rs 707 crore a year ago. On a sequential basis, the profit grew 12 percent.

The Hyderabad-based drugmaker also reported a 27 percent increase in consolidated revenue at Rs 6,770 crore as against Rs 5,320 crore in the year-ago period, while it was up 7 percent sequentially.

"Our strong financial performance was supported by growth in the US and the Russia markets. We continue to strengthen our development pipeline to reach more patients globally," Co-chairman & MD, G V Prasad, commented on its performance.

ALSO READ: Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate